Clinical trials: Neonatal Critical Illness
Newborn Morbidity, Newborn Complication
Feasibility Study Evaluating the Efficacy of a Wireless Vital Signs Monitor for Critically Ill Newborns in Kenya
The neoGuard device is a 4-in-1 wearable vital signs monitor designed to continuously measure temperature, pulse rate (PR), respiratory rate (RR) and blood oxygen saturation (SpO2) in newborns.
- Trial name
- NCT04606589
- Testing
- neoGuard vital signs monitor
- Where
- Kenya
- Volunteers
- 167 people
- Sponsor
- Neopenda, PBC